Shanghai Kaibao Pharmaceutical CO.,Ltd announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 538.040 million compared to CNY 475.581 million a year ago. Operating income was CNY 100.434 million compared to CNY 94.435 million a year ago. Net income was CNY 81.790 million compared to CNY 76.941 million a year ago. Basic earnings per share from continuing operations was CNY 0.0782 compared to CNY 0.0736 a year ago.